Watchlist Price Alert

Regeneron Pharmaceuticals... (REGN)

NASDAQ: REGN · Real-Time Price · USD

594.50

9.51 (1.63%)

At close: May 16, 2025, 3:59 PM

592.89

-0.27%

Pre-market: May 19, 2025, 06:15 AM EDT

Regeneron Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	2.49B	2.73B	3.11B	2.89B	2.19B	1.62B	1.47B	812.73M	535.2M
Short-Term Investments	6.52B	8.11B	4.64B	2.81B	1.39B	1.6B	1.34B	596.85M	503.48M
Long-Term Investments	8.9B	5.4B	5.41B	6.84B	3.14B	3.26B	1.75B	1.49B	864.26M
Other Long-Term Assets	1.14B	444.1M	-4.66B	555.2M	328.9M	531.8M	370.7M	302.84M	150.82M
Receivables	6.21B	5.67B	5.33B	6.04B	4.11B	2.1B	2.24B	1.97B	1.61B
Inventory	3.09B	2.58B	2.4B	1.95B	1.92B	1.42B	1.15B	726.14M	399.36M
Other Current Assets	349.2M	386.6M	n/a	332.4M	n/a	92.2M	n/a	224.97M	n/a
Total Current Assets	18.66B	19.48B	22.06B	20.52B	12.75B	10.56B	7.96B	5.6B	3.91B
Property-Plant & Equipment	4.6B	4.15B	3.76B	3.48B	3.22B	2.89B	2.58B	2.36B	2.08B
Goodwill & Intangibles	1.15B	1.04B	915.5M	-6.84B	-3.14B	-3.26B	-1.75B	-1.49B	-864.26M
Total Long-Term Assets	19.1B	13.6B	7.15B	4.91B	4.41B	4.25B	3.78B	3.17B	3.06B
Total Assets	37.76B	33.08B	29.21B	25.43B	17.16B	14.81B	11.73B	8.76B	6.97B
Account Payables	789.5M	606.6M	589.2M	564M	475.5M	418.1M	218.2M	178.2M	134.98M
Deferred Revenue	627.7M	458.9M	547.7M	442M	577.7M	591.7M	452.5M	320.14M	231.66M
Short-Term Debt	n/a	n/a	n/a	719.7M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	2.31B	41.6M	1.58B	2.09B	n/a	1.33B	489.5M	-168.08M	1.18M
Total Current Liabilities	3.94B	3.42B	3.85B	3.45B	2.81B	1.79B	1.35B	967.42M	980.66M
Long-Term Debt	1.98B	1.98B	1.98B	1.98B	1.98B	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.48B	854.1M	638M	680.2M	687.1M	395.3M	546.6M	949.29M	100.39M
Total Long-Term Liabilities	4.46B	3.68B	2.7B	3.21B	3.33B	1.92B	1.63B	1.65B	1.54B
Total Liabilities	8.41B	7.11B	6.55B	6.67B	6.14B	3.72B	2.98B	2.62B	2.52B
Total Debt	2.7B	2.7B	2.7B	2.7B	2.7B	713.9M	708.5M	703.45M	481.13M
Common Stock	100K	100K	100K	100K	100K	100K	100K	112K	110K
Retained Earnings	31.67B	27.26B	23.31B	18.97B	10.89B	7.38B	5.25B	2.95B	1.75B
Comprehensive Income	-7.9M	-80.9M	-238.8M	-26.2M	29.3M	21.1M	-12.3M	640K	-12.84M
Shareholders Equity	29.35B	25.97B	22.66B	18.77B	11.03B	11.09B	8.76B	6.14B	4.45B
Total Investments	15.42B	13.51B	10.04B	9.65B	4.53B	4.85B	3.1B	2.08B	1.37B